This inventor holds 6 USPTO granted patents. Top assignees: Research Corporation Technologies, Inc., The Mclean Hospital Corporation, University of Rochester. Active years: 1993-1999.
Company Filing History:
4 out of 366 
2 out of 125 
2 out of 994 
Years Active: 1993-1999
Title: Sayeeda Zain: Innovator in Cancer Diagnosis
Introduction
Sayeeda Zain is a prominent inventor based in Pittsford, NY (US). She has made significant contributions to the field of cancer diagnosis, holding a total of 6 patents. Her work focuses on innovative methods for detecting metastatic cancer, which can greatly enhance early diagnosis and treatment options.
Latest Patents
One of her latest patents is titled "Diagnosis of metastatic cancer by the mts-1 gene." This invention is directed towards diagnosing malignant cancer through the detection of the mts-1 mRNA or the mts-1 protein, which is encoded by the mts-1 gene. The invention utilizes recombinant mts-1 DNA and antibodies against the mts-1 protein to assess the metastatic potential of various tumor cells, including those from the thyroid, lungs, liver, and kidneys. Additionally, her work includes the development of mammalian cell lines and tumors with varying metastatic potentials, which serve as valuable model systems for in vitro and in vivo anti-metastasis drug screening.
Another significant patent is "Methods of diagnosing metastatic cancer with MTS-1 protein." This patent shares similar objectives as her previous work, emphasizing the importance of the mts-1 gene in cancer diagnosis. The methodologies proposed in her patents aim to improve the accuracy and efficiency of cancer detection, ultimately benefiting patient outcomes.
Career Highlights
Throughout her career, Sayeeda Zain has worked with notable organizations, including Research Corporation Technologies, Inc. and The McLean Hospital Corporation. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer diagnostics.
Collaborations
Sayeeda has collaborated with esteemed colleagues such as Eugene Lukanidin and Charles A. Marotta. These partnerships have further enriched her research and innovation in the medical field.
Conclusion
Sayeeda Zain's contributions to cancer diagnosis through her innovative patents highlight her dedication to improving healthcare outcomes. Her work continues to pave the way for advancements in the detection and treatment of metastatic cancer.